topics Corporate /en/research-insights/topics/life-sciences content esgSubNav

Life Sciences

Life science industry growth is supported by increased demand from an aging population and scientific advancements that support a steady stream of new products. However, this is partially offset by a moderate erosion in pricing power for drug makers.

FDA Orange Book

Datasets & Solutions

The FDA Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA. This dataset relates a named drug to a set of compounds and to the drug owner.

Markets in Motion

Cultivate a deeper understanding of global events and market dynamics from all angles with Markets in Motion from S&P Global. Our weekly newsletter features macro and micro perspectives of the issues driving markets and the global economy, shaped by the news and insights produced across S&P Global's peerless research teams.

Access all reports
March 22, 2021
Markets in Motion: COVID-19 & the Future of Healthcare

In a post-pandemic world, the global healthcare industry may be unrecognizable due to the crisis’ acceleration of disruption. The future of healthcare will likely be shaped by technology and innovation.

Read the Report


S&P Global Market Intelligence

Stay ahead of healthcare developments with essential data, news, and insights.

Related Events & Webinars

COVID-19 News & Analysis

S&P Global Market Intelligence

The COVID-19 pandemic continues to weigh heavily on the global economy, taking a toll on key industries. Our news, data, and analysis give you the essential intelligence you need to make sense of the markets.